Incidence of venous thromboembolic disease and risk of bleeding in critically ill patients with hematologic malignancies: A retrospective study Federico C. Carini; Laveena Munshi; Igor Novitzky-Basso; Graham Dozois; Camila Heredia; Sotirios Damouras; Bruno L. Ferreyro; Sangeeta Mehta;

Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients in the coronavirus disease (COVID-19) M.Á. Ballesteros Sanz; A. Hernández-Tejedor; Á. Estella; J.J. Jiménez Rivera; F.J. González de Molina Ortiz; A. Sandiumenge Camps; P. Vidal Cortés; C. de Haro; E. Aguilar Alonso; L. Bordejé Laguna; I. García Sáez; M. Bodí; M. García Sánchez; M.J. Párraga Ramírez; R.M. Alcaraz Peñarrocha; R. Amézaga Menéndez; P. Burgueño Laguía;

Anti-Xa activity below range is related to thrombosis in patients with severe COVID-19 Pilar Marcos-Neira; Cristian Morales-Indiano; Mariana Fernández-Caballero; Teresa Tomasa-Irriguible; Luisa Bordejé-Laguna; Víctor Ruíz-Artola;